Concord Drugs Ltd

BSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Concord Drugs Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
41.77% Fall from 52W High
-22.1
TTM PE Ratio
Below industry Median
39.6
Price to Book Ratio
Low in industry
1.1
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-44.5
RSI
RSI is mid-range
38.5
MFI
MFI is mid-range
49.8

Concord Drugs Ltd shareholding Pattern

Promoter
55.4%
Public
44.6%
Promoter
55.4%
Public
44.6%
Promoter
52.1%
Public
47.9%
Promoter
52.1%
Public
47.9%
Promoter
52.1%
Public
47.9%
Promoter
49%
Public
51%

Concord Drugs Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
5Day EMA
36.20
10Day EMA
36.60
12Day EMA
36.60
20Day EMA
36.80
26Day EMA
37.00
50Day EMA
37.80
100Day EMA
38.50
200Day EMA
37.40
5Day SMA
36.50
10Day SMA
36.80
20Day SMA
37.10
30Day SMA
36.70
50Day SMA
37.40
100Day SMA
41.30
150Day SMA
39.00
200Day SMA
37.80
Delivery & Volume
Resistance & Support
36.12
Pivot
Resistance
First Resistance
37.13
Second Resistance
38.79
Third Resistance
39.80
Support
First Support
34.46
Second support
33.45
Third Support
31.79
Relative Strength Index
38.51
Money Flow Index
49.84
MACD
-0.35
MACD Signal
-0.27
Average True Range
2.01
Average Directional Index
13.15
Rate of Change (21)
-2.18
Rate of Change (125)
7.58
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Veerhealth Care Ltd.
-
-
-
Vivanza Biosciences Ltd.
-
-
-
Concord Drugs Ltd.
-
-
-
Murae Organisor Ltd.
-
-
-
JFL Life Sciences Ltd.
-
-
-
Vilin Bio Med Ltd.
-
-
-
Sunrest Lifescience Ltd.
-
-
-

Concord Drugs Ltd Company background

Founded in: 1995
Managing director: S Nagi Reddy
CONCORD DRUGS LIMITED is a public limited company established in 1995, is among the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small volume parenterals, Dry powder ) ,Tissue BioAdhesive, tablets, capsules and ophthalmic preparations and Readytofill Pellets.State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Readytofill Pellets ensures the highest level of process integrity and product quality.The company started with Finished Pharmaceutical Formulations and then diversified into Readytofill Pellets, to provide our customers with endtoend solution to their various pharmaceutical product needs to commercial contract drug manufacturing.The company operates a state of the art, cGMP contract manufacturing FormulationFillFinish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products.The company has two manufacturing facilities built to comply with standards stipulated by Regulatory bodies.
Read More

Concord Drugs Ltd FAQs

You can easily buy Concord Drugs Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage